# Stay up-to-date with our latest news

## Announcements

### July 2, 2026
**Evidation Insights from 165,000 People Show Continued Growth Potential Amid Uneven Adoption in the GLP-1 Market**  
Among 119,000 surveyed individuals actively trying to lose weight, 24% had ever used prescription medication for weight management and 15% had ever used a GLP-1, suggesting significant room for continued market growth as adoption varies by age, gender, and income.  
Read [here](https://legal@evidation.com/resources/growth-potential-and-uneven-adoption-in-the-glp-1-market)

### January 8, 2026
**Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research**  
Read [here](https://legal@evidation.com/resources/evidation-launches-temporal-proteomics-platform-and-autoimmune-cohort)

### December 16, 2025
**Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals**  
Read [here](https://legal@evidation.com/resources/real-world-glp-1-dosing-behaviors)

### December 2, 2025
**Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer**  
Read [here](https://legal@evidation.com/resources/evidation-appoints-dr-ghazanfar-khan-as-chief-medical-officer)

### March 6, 2025
**Evidation Appoints Leslie Oley Wilberforce as CEO**  
Read [here](https://legal@evidation.com/resources/evidation-appoints-leslie-oley-wilberforce-as-ceo)

### October 3, 2024
**Evidation appoints Phil Johnson as Chief Commercial Officer**  
Read [here](https://legal@evidation.com/resources/evidation-appoints-phil-johnson-as-chief-commercial-officer)

### September 17, 2024
**Trialbee and Evidation partner to accelerate and diversify clinical research recruitment**  
Read [here](https://legal@evidation.com/resources/trialbee-and-evidation-partner-to-accelerate-and-diversify-clinical-research-recruitment)

### July 15, 2024
**Rock Health shares findings from weight care survey with Evidation**  
Read [here](https://legal@evidation.com/resources/rock-health-shares-findings-from-weight-care-survey-with-evidation)

### July 1, 2024
**Frost & Sullivan awards Evidation for its direct-to-participant real world data solutions**  
Read [here](https://legal@evidation.com/resources/frost-sullivan-awards-evidation-for-its-direct-to-participant-real-world-data-solutions)

### June 20, 2024
**Evidation launches MigraineSmart on the Evidation app**  
Read [here](https://legal@evidation.com/resources/evidation-launches-migrainesmart-a-migraine-tracking-program-incorporating-wearable-data-on-the-evidation-app)

### May 6, 2024
**Evidation shares real world data on GLP-1 use and social determinants of health at ISPOR 2024**  
Read [here](https://legal@evidation.com/resources/evidation-shares-real-world-data-on-glp-1-use-and-social-determinants-of-health-at-ispor-2024)

### November 16, 2023
**Evidation selected by Our Future Health as participant platform for UK’s largest health research program**  
Read [here](https://legal@evidation.com/resources/evidation-selected-by-our-future-health-as-participant-platform-for-uks-largest-health-research-program)

### October 17, 2023
**BARDA expands partnership with Evidation to validate and improve machine learning models for early detection of influenza-like illness using wearables**  
Read [here](https://legal@evidation.com/resources/barda-expands-partnership-with-evidation-to-validate-and-improve-machine-learning-models-for-early-detection-of-influenza-like-illness-using-wearables)